Monthly Archives: October 2018

20 October 2018

DefiniGEN – Parkwalk closes follow on investment

By |October 20th, 2018|

Parkwalk closes DefiniGen investment.

DefiniGEN, a spin-out from the University of Cambridge Regenerative Medicine Department at Addenbrooke’s Hospital, have created a stem cell technology to provide human cells to the drug discovery sector for use in lead optimisation and toxicity programmes.

The Company’s proprietary production platform OptiDIFF robustly generates human cell types including using hIPSC human […]

Congenica – earns major role in supporting world’s first routine national genomic medicine service

By |October 17th, 2018|

Genomics England names Congenica as its Clinical Decision Support Service partner for the delivery of the NHS Genomic Medicine Service

Cambridge, United Kingdom – 17 October, 2018 – Congenica has been awarded a multi-year contract by Genomics England, to be a provider of Diagnostic Decision Support Services for them to deliver for the world leading NHS Genomic […]

Oxbotica – appoints Fraser Robinson to drive global strategy

By |October 12th, 2018|

Oxbotica, the autonomous software company, today announces the appointment of Fraser Robinson to its board of directors. This follows Oxbotica’s recent completion of a £14 million investment which will support the next stage of its international development.

Robinson comes with a rare and proven track record, most recently leading Uber’s investment negotiations, strategy and partnerships […]

Vitamica – University of Bristol Enterprise Fund II investment

By |October 9th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Vitamica, a University of Bristol spin-out that aims to exploit a novel approach for determining the susceptibility of bacteria to antibiotics.

Resistance of bacteria to antibiotics is an increasing problem across the world, resulting in poorer healthcare […]

Paragraf – Large-scale production of graphene-based technologies

By |October 6th, 2018|

Paragraf, the Cambridge graphene start-up, has followed its seed investment of £2.9m, announced in May 2018, with the opening of a groundbreaking new facility

The site represents a turning point for graphene-based technologies, enabling Paragraf to drive large-scale development of mass-market, graphene-based electronic devices.

Paragraf’s proprietary production technique overcomes the quality, contamination and reproducibility barriers faced […]

Arkivum – Jersey Heritage contract

By |October 1st, 2018|

Jersey Heritage has chosen Arkivum Perpetua to store and preserve the huge volumes of digital records in its care. Holding the complete public record of States of Jersey, a photo archive of around 1.5 million images and digitised artefacts such as registration cards from the German occupation during World War Two, Jersey Heritage tells […]